 On July 22, both The Jerusalem Post and Forbes reported that Oravax Medicals oral COVID vaccine candidate is about to begin a phase 1 trial in Israel. While Israel is said to be first in world to test Oravax oral COVID vaccine, Vaxart, a US-based company, has completed a phase 1 trial of their oral COVID vaccine. 